Published in Cancer Weekly, August 16th, 2005
The grant application was submitted in response to president Bush's Executive Order encouraging innovation in manufacturing-related research and development. Altor's long-term goal in this project is to use its plant expression system to produce a variety of immunotherapeutic drugs at very low manufacturing costs.
Valentin Negrouk, PhD, senior scientist and principal investigator of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.